Johan Neyts Selected Research

2- (3,4- dichlorophenoxy)- 5- nitrobenzonitrile

2/2004

Inhibition of coxsackie B3 virus induced myocarditis in mice by 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Neyts Research Topics

Disease

108	Infections 08/2022 - 01/2003
30	COVID-19 08/2022 - 01/2020
16	Diarrhea 03/2020 - 04/2006
15	Hepatocellular Carcinoma (Hepatoma) 11/2018 - 04/2006
12	Virus Diseases (Viral Diseases) 01/2022 - 01/2008
10	Human Influenza (Influenza) 10/2021 - 05/2003
10	Dengue (Dengue Fever) 01/2021 - 08/2002
9	Neoplasms (Cancer) 10/2021 - 06/2012
8	Yellow Fever 01/2022 - 01/2018
7	Caliciviridae Infections 08/2021 - 08/2010
7	Gastroenteritis 07/2021 - 11/2013
6	Inflammation (Inflammations) 06/2021 - 08/2006
6	Poliomyelitis (Polio) 01/2017 - 04/2008
6	Hepatitis C 05/2016 - 06/2007
5	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016 - 10/2013
5	Myocarditis (Carditis) 11/2015 - 12/2003
5	Vaccinia 01/2012 - 01/2003
4	Encephalitis (Encephalitis, Rasmussen) 06/2021 - 02/2003
4	Fibrosis (Cirrhosis) 06/2021 - 08/2006
4	Disease Progression 12/2018 - 02/2003
4	Persistent Infection 01/2018 - 01/2003
4	Enterovirus Infections 10/2013 - 06/2011
4	Poxviridae Infections 10/2010 - 09/2002
4	Smallpox (Variola) 02/2006 - 01/2003
4	Mpox (monkeypox) 02/2006 - 09/2002
3	Coronavirus Infections 06/2021 - 08/2012
3	Severe Acute Respiratory Syndrome 01/2021 - 04/2005
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2012
3	Acquired Immunodeficiency Syndrome (AIDS) 02/2015 - 09/2004
3	Herpesviridae Infections (Herpesvirus Infection) 11/2014 - 01/2007
3	Pancreatitis 10/2013 - 12/2008
3	Chronic Hepatitis B 06/2010 - 01/2008
3	Flavivirus Infections 01/2006 - 02/2003
2	Carcinoma (Carcinomatosis) 10/2021 - 10/2008
2	Necrosis 08/2021 - 08/2006
2	Zoonoses 04/2021 - 01/2021
2	Malaria 01/2021 - 10/2004
2	Bites and Stings (Sting) 01/2020 - 01/2020
2	Respiratory Syncytial Virus Infections 01/2020 - 01/2017
2	Measles 01/2020 - 01/2019
2	Zika Virus Infection 01/2020 - 01/2018
2	Rabies (Hydrophobia) 01/2019 - 01/2019
2	Chikungunya Fever 01/2018 - 06/2015
2	Asthma (Bronchial Asthma) 01/2017 - 01/2012
2	Hepatitis B 01/2017 - 12/2015
2	Alzheimer Disease (Alzheimer's Disease) 04/2016 - 04/2016
2	Hypercholesterolemia 05/2014 - 07/2009

Drug/Important Bio-Agent (IBA)

109	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2002
41	VaccinesIBA 06/2022 - 02/2006
22	Pharmaceutical PreparationsIBA 07/2021 - 09/2002
16	Ribavirin (Virazole)FDA LinkGeneric 11/2020 - 01/2003
11	InterferonsIBA 08/2021 - 02/2003
10	Viral RNAIBA 01/2021 - 04/2005
9	AntibodiesIBA 08/2022 - 02/2006
9	NucleosidesIBA 04/2019 - 09/2004
7	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2005
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2003
7	Biological ProductsIBA 01/2019 - 02/2006
7	Cidofovir (Vistide)FDA Link 01/2018 - 01/2003
6	Neutralizing AntibodiesIBA 01/2022 - 01/2019
6	favipiravirIBA 10/2021 - 10/2014
5	Subgenomic RNAIBA 01/2021 - 04/2006
4	Monoclonal AntibodiesIBA 08/2022 - 01/2021
4	Glycoproteins (Glycoprotein)IBA 09/2021 - 12/2012
4	Peptide Hydrolases (Proteases)FDA Link 03/2014 - 08/2006
4	Interferon-alpha (Interferon Alfa)IBA 10/2013 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 06/2012
3	Broadly Neutralizing AntibodiesIBA 11/2021 - 01/2021
3	molnupiravirIBA 10/2021 - 01/2021
3	Itraconazole (Sporanox)FDA LinkGeneric 07/2021 - 04/2021
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	AntigensIBA 01/2021 - 01/2016
3	7-deaza-2'-C-methyladenosineIBA 04/2019 - 01/2016
3	LuciferasesIBA 01/2017 - 04/2006
3	EnzymesIBA 12/2015 - 01/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015 - 07/2009
3	NucleotidesIBA 06/2014 - 09/2004
2	Ivermectin (Mectizan)FDA Link 03/2022 - 08/2012
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 10/2010
2	remdesivirIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2018
2	CytokinesIBA 06/2021 - 08/2006
2	ProdrugsIBA 03/2021 - 09/2004
2	quinolineIBA 01/2021 - 01/2018
2	Immunologic Factors (Immunomodulators)IBA 04/2020 - 02/2003
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2019 - 01/2017
2	bryostatin 1IBA 04/2016 - 04/2016
2	2'-C-methylcytidineIBA 01/2016 - 11/2013
2	Viral AntigensIBA 01/2016 - 04/2006
2	SteroidsIBA 01/2016 - 06/2014
2	SofosbuvirIBA 01/2016 - 08/2015
2	Scavenger Receptors (Scavenger Receptor)IBA 03/2015 - 02/2013
2	Cyclophilins (Cyclophilin)IBA 02/2015 - 06/2014
2	Oxidoreductases (Dehydrogenase)IBA 06/2014 - 06/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 06/2014 - 12/2003
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2014 - 12/2003
2	Inosine Monophosphate (IMP)IBA 06/2014 - 06/2012
2	Coenzyme A (CoA)IBA 05/2014 - 07/2009

Therapy/Procedure

40	Therapeutics 01/2022 - 01/2003
2	Off-Label Use 03/2022 - 01/2020